Works by Wang, Hongyuan


Results: 138
    1
    2
    3

    Menu Text Recognition of Few-shot Learning.

    Published in:
    Journal of New Media, 2022, v. 4, n. 3, p. 137, doi. 10.32604/jnm.2022.027890
    By:
    • Xiaoyu;
    • Tian Zhenzhen;
    • Xin Zihao;
    • Liu Suolan;
    • Chen Fuhua;
    • Wang Hongyuan
    Publication type:
    Article
    4
    5
    6
    7
    8
    9

    Plastic pollution in croplands threatens long‐term food security.

    Published in:
    Global Change Biology, 2020, v. 26, n. 6, p. 3356, doi. 10.1111/gcb.15043
    By:
    • Zhang, Dan;
    • Ng, Ee Ling;
    • Hu, Wanli;
    • Wang, Hongyuan;
    • Galaviz, Pablo;
    • Yang, Hude;
    • Sun, Wentao;
    • Li, Chongxiao;
    • Ma, Xingwang;
    • Fu, Bin;
    • Zhao, Peiyi;
    • Zhang, Fulin;
    • Jin, Shuqin;
    • Zhou, Mingdong;
    • Du, Lianfeng;
    • Peng, Chang;
    • Zhang, Xuejun;
    • Xu, Zhiyu;
    • Xi, Bin;
    • Liu, Xiaoxia
    Publication type:
    Article
    10

    Eight‐year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 11/12, p. 1573, doi. 10.1111/apt.18278
    By:
    • Buti, Maria;
    • Lim, Young‐Suk;
    • Chan, Henry Lik Yuen;
    • Agarwal, Kosh;
    • Marcellin, Patrick;
    • Brunetto, Maurizia R.;
    • Chuang, Wan‐Long;
    • Janssen, Harry L. A.;
    • Fung, Scott K.;
    • Izumi, Namiki;
    • Jablkowski, Maciej S.;
    • Abdurakhmanov, Dzhamal;
    • Abramov, Frida;
    • Wang, Hongyuan;
    • Botros, Irina;
    • Yee, Leland J.;
    • Mateo, Roberto;
    • Flaherty, John F.;
    • Osinusi, Anu;
    • Pan, Calvin Q.
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 2, p. 217, doi. 10.1111/apt.17764
    By:
    • Fung, Scott K.;
    • Pan, Calvin Q.;
    • Wong, Grace Lai‐Hung;
    • Seto, Wai‐Kay;
    • Ahn, Sang Hoon;
    • Chen, Chi‐Yi;
    • Hann, Hie‐Won L.;
    • Jablkowski, Maciej S.;
    • Kim, Yoon Jun;
    • Yurdaydin, Cihan;
    • Peng, Cheng‐Yuan;
    • Nguyen, Tuan;
    • Yatsuhashi, Hiroshi;
    • Flaherty, John F.;
    • Yee, Leland J.;
    • Abramov, Frida;
    • Wang, Hongyuan;
    • Abdurakhmanov, Dzhamal;
    • Lim, Young‐Suk;
    • Buti, Maria
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50